- Home
- GIFT vs SYRS Comparison
GIFT vs SYRS Comparison
Compare GIFT & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIFT
- SYRS
- Stock Information
- Founded
- GIFT 1999
- SYRS 2011
- Country
- GIFT United States
- SYRS United States
- Employees
- GIFT N/A
- SYRS 68
- Industry
- GIFT Catalog/Specialty Distribution
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- GIFT Consumer Discretionary
- SYRS Health Care
- Exchange
- GIFT Nasdaq
- SYRS Nasdaq
- Market Cap
- GIFT 50.0M
- SYRS 52.5M
- IPO Year
- GIFT N/A
- SYRS 2016
- Fundamental
- Price
- GIFT $1.87
- SYRS $1.96
- Analyst Decision
- GIFT
- SYRS Strong Buy
- Analyst Count
- GIFT 0
- SYRS 3
- Target Price
- GIFT N/A
- SYRS $5.00
- AVG Volume (30 Days)
- GIFT 53.3K
- SYRS 357.3K
- Earning Date
- GIFT 11-15-2024
- SYRS 11-12-2024
- Dividend Yield
- GIFT N/A
- SYRS N/A
- EPS Growth
- GIFT N/A
- SYRS N/A
- EPS
- GIFT N/A
- SYRS N/A
- Revenue
- GIFT $83,435,815.00
- SYRS $4,149,000.00
- Revenue This Year
- GIFT N/A
- SYRS N/A
- Revenue Next Year
- GIFT N/A
- SYRS $614.29
- P/E Ratio
- GIFT N/A
- SYRS N/A
- Revenue Growth
- GIFT N/A
- SYRS N/A
- 52 Week Low
- GIFT $0.50
- SYRS $1.43
- 52 Week High
- GIFT $4.65
- SYRS $8.17
- Technical
- Relative Strength Index (RSI)
- GIFT N/A
- SYRS 44.14
- Support Level
- GIFT N/A
- SYRS $1.85
- Resistance Level
- GIFT N/A
- SYRS $2.03
- Average True Range (ATR)
- GIFT 0.00
- SYRS 0.14
- MACD
- GIFT 0.00
- SYRS 0.08
- Stochastic Oscillator
- GIFT 0.00
- SYRS 27.66
About GIFT RDE Inc. Common Stock
RDE Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup. The Company also derives revenue from the sale of discount certificates for restaurants on behalf of third-party restaurants.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.